This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Chief Financial Officer & Chief Operating Officer
Mr. Levy has over 15 years of experience in finance and administration.
Prior to joining BrainsWay, Mr. Levy served as a finance manager in the Latin America Division at Amdocs Ltd., where he was responsible for accounting, financial reporting, treasury, portfolio management and finance support for Mergers & Acquisitions.
Prior to Amdocs, he served as Chief Financial Officer & Business Development of Notal Vision, a healthcare company that researches and develops medical technologies for detecting retinal malfunction and deterioration, where he was responsible for all financial functions, and lead financial rounds of equity including M&A activities with strategic partners.
Prior to this position, he served as Controller of GE Healthcare Israel.
Mr. Levy began his career at Deloitte LLP, holds a BA in Accounting and Economics and an LLM degree from Bar Ilan University and is a Certified Public Accountant.